Biotech Leader Travere Therapeutics Eyes Buy Point After More Than Doubling
Travere Therapeutics(US:TVTX) Investors·2025-10-23 16:01BREAKING: Crude Oil Jumps 5% On Trump Move Thursday's IBD 50 Growth Stocks To Watch pick, biotech leader Travere Therapeutics (TVTX), is approaching its latest buy point after more than doubling since mid-June. That makes Travere stock one of the best names to watch right now, with the market under some moderate selling pressure in recent sessions. In mid-September, shares soared more than 26% after the Food and… Related news Travere Therapeutics Receives Composite Rating Upgrade 9/21/2025The IBD SmartSelec ...